|
|
730 Central Avenue Murray Hill, NJ 07974 USA phone:(908) 277-8000 fax:(908) 277-8412
|
|
| Symbol |
BCR |
| Exchange |
NYSE |
| Founded |
2007 |
| Employees |
7700 |
|
|
| www.crbard.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Surgical, diagnostic and patient care devices. |
 |
| Management |
| Timothy M. Ring, Chairman and Chief Executive Officer; John H. Weiland, President and Chief Operating Officer; David M. Barrett, M.D., President and Chief Executive Officer; Marc C. Breslawsky, Retired Chairman and Chief Executive Officer; T. Kevin Dunnigan, Retired Chairman |
| |
|
|
|
|
|
|
|
| Keywords |
| vascular, urology, oncology, surgical specialty, technological |
|
|
|
| Description |
|
C. R. Bard, Inc. designs, manufactures, packages, distributes and sells medical, surgical, diagnostic and patient care devices that are purchased by hospitals, physicians and nursing homes, many of which are used once and discarded. Bard holds market positions in vascular, urological, oncological and surgical diagnostic and interventional products. |
 |
| Market / Customers |
Its products for the peripheral vascular market include interventional radiology products, electrophysiology products and graft products. The Company's products for the urological market include basic drainage products, continence products and urological specialty products. Its oncological products include specialty access products and gastroenterological products. The Company surgical products include ventral hernia products, performance irrigation products, topical hemostatic products and products for topical hemostasis.
|
 |
|
|
|
|
|
|